Xue Hu

589 citations
21 papers · 422 indexed · h-index 13
Topics
Genomics, phytochemicals, and oxidative stress (2 papers)PI3K/AKT/mTOR signaling in cancer (2 papers)Cell death mechanisms and regulation (2 papers)

In The Last Decade

Xue Hu

20 papers receiving 420 citations

Peers

Xue Hu
Comparison fields: 5 of 90
  • Molecular Biology 184
  • Immunology 66
  • Complementary and alternative medicine 56
  • Cancer Research 49
  • Surgery 47
Replace Shan Su with:
Shan Su China
Hong-Zin Lee Taiwan
Yu-An Hsu Taiwan
Xinying Zhu China
Bendangla Changkija India
Tiantian Xu China
Mi Hwa Han South Korea
Nisansala Chandimali South Korea
MyongHak Ri China
Hongming Zheng China
Xue Hu relative to Shan Su China Shan Su's profile →
Citations per field
00.5×1.5×1.8×
Shan Su · 1×
Citations per year

Countries citing papers authored by Xue Hu

Since Specialization
Citations

This map shows the geographic impact of Xue Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Hu more than expected).

Fields of papers citing papers by Xue Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Hu. The network helps show where Xue Hu may publish in the future.

Co-authorship network of co-authors of Xue Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Xue Hu. A scholar is included among the top collaborators of Xue Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue Hu. Xue Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 2
3 9
4 4
5 16
6 2
7 3
8 22
9 15
10 19
11 33
12 13
13 26
14 37
15 28
16 28
17 33
18
Efficacy and prognostic factors of cyberknife treatment combined with transcatheter arterial chemoembolization therapy for primary liver cancer
0
19 18
20
Intensive glycemic control and macrovascular events in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.
10

About Xue Hu

Xue Hu is a scholar working on Toxicology, Hepatology and Complementary and alternative medicine, having authored 21 papers that have together received 422 indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Toxicology (30 citations), Complementary and alternative medicine (56 citations) and Pharmacology (47 citations). Xue Hu has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Jixiang Zhang, Jingjing Ma, Dandan Wu, Weiguo Dong, Jiao Li, Jing Yang, Tailang Yin, Lu Yin, Mu Yang and Jinli Ding. Their work appears in journals such as PLoS ONE, Analytical Biochemistry and Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026